Chief Financial Officer Markovits Joel covered exercise/tax liability with 33,651 shares, sold $14,569 worth of shares (10,603 units at $1.37) and was granted 234,221 shares, increasing direct ownership by 1,753% to 200,803 units (SEC Form 4)
$RELI
Specialty Insurers
Finance
| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
| Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. | |||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
Reliance Global Group, Inc. [ RELI ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 08/01/2024 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Common Stock | 08/01/2024 | F(1) | 8 | D | $3.6 | 10,828 | D | |||
| Common Stock | 09/04/2024 | F(1) | 9 | D | $2.67 | 10,819 | D | |||
| Common Stock | 10/02/2024 | F(1) | 9 | D | $2.36 | 10,810 | D | |||
| Common Stock | 11/01/2024 | F(1) | 10 | D | $2.38 | 10,800 | D | |||
| Common Stock | 11/22/2024 | S | 10,603 | D | $1.374 | 197 | D | |||
| Common Stock | 12/02/2024 | F(1) | 12 | D | $1.54 | 185 | D | |||
| Common Stock | 01/02/2025 | F(1) | 10 | D | $2.89 | 175 | D | |||
| Common Stock | 01/21/2025 | A | 185,221(2) | A | $0 | 185,396 | D | |||
| Common Stock | 02/04/2025 | F(3) | 16,537 | D | $1.9566 | 168,859 | D | |||
| Common Stock | 02/05/2025 | A | 49,000(4) | A | $0 | 217,859 | D | |||
| Common Stock | 02/07/2025 | F(3) | 17,056 | D | $1.8815 | 200,803 | D | |||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Explanation of Responses: |
| 1. Represents the payment of tax liability by delivering securities incident to the receipt of a previously reported stock grant, which was issued in accordance with Rule 16b-3. This transaction is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). |
| 2. Represents the grant of shares of common stock, approved by the compensation committee, comprised solely of independent directors, of the issuer's board of directors and issued in accordance with Rule 16b-3 promulgated under the Exchange Act. The grant vests (i) with respect to 37,045 shares on January 27, 2025; and (ii) with respect to 37,044 shares on each of February 3, 2025, July 15, 2025, July 30, 2025, and August 15, 2025. |
| 3. Represents the payment of tax liability incident to the receipt of the January 21, 2025 stock grant, which was issued in accordance with Rule 16b-3 pursuant to the Exchange Act. This transaction is exempt from Section 16(b) of the Exchange Act. |
| 4. Represents the grant of shares of common stock, approved by the compensation committee, comprised solely of independent directors, of the issuer's board of directors and issued in accordance with Rule 16b-3 promulgated under the Exchange Act. The grant vests (i) with respect to 16,334 shares on August 30, 2025; and (ii) with respect to 16,333 shares on each of September 15, 2025, and September 30, 2025. |
| /s/ Joel Markovits | 02/11/2025 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||